Severe ME/CFS: CBF reduced at only 20 degrees of tilt
Standard orthostatic testing assumes that patients can tolerate being tilted upright to 70 degrees for 30 minutes. This assumption excludes the most severely affected ME/CFS patients by design. A patient who is bedbound — who cannot tolerate sustained upright posture, for whom sitting in a chair produces symptom worsening, and for whom the standard test protocol would be physically impossible — cannot be evaluated using a protocol built for moderately impaired patients. A 2023 study by van Campen, Rowe, and colleagues published in Healthcare addressed this problem directly, applying a modified protocol with only 20 degrees of tilt to severe ME/CFS patients who could not tolerate conventional testing. The result: even at 20 degrees, these patients showed significant cerebral blood flow reduction and orthostatic symptoms. The standard test's premise — that 70 degrees of tilt is the minimum meaningful stimulus — was wrong for this population by a factor of 3.5.
The Standard Protocol Excludes the Most Severely Affected Patients
The conventional head-up tilt table test for orthostatic intolerance uses 70 degrees of tilt, held for up to 30 minutes, with or without pharmacological provocation. This protocol was developed for ambulatory patients who can tolerate extended upright posture and who present with syncope or pre-syncope as their primary complaint. The diagnostic thresholds — 30 bpm heart rate increase for POTS, defined blood pressure drops for orthostatic hypotension — were calibrated for this population.
For patients with severe ME/CFS, this protocol is physiologically inaccessible. These are patients who cannot sit upright for extended periods without post-exertional worsening, for whom a clinical appointment requiring a 70-degree tilt for half an hour represents an exertional challenge that will produce days of increased symptom burden. Applying the standard protocol to evaluate them does not produce a valid test result. It produces a test that many cannot complete, and for those who do complete it, the result is evaluated against thresholds calibrated for a different population with a different physiological reserve.
The van Campen and Rowe research program has progressively documented the cerebral blood flow consequences of orthostatic stress in ME/CFS patients across the severity spectrum. Earlier work established that sitting alone can produce CBF reductions of nearly 25% in severe ME/CFS patients without any change in heart rate or blood pressure. The 2023 study extended this to the question of formal tilt protocols: what is the minimum tilt angle that produces measurable CBF change in bedbound patients who cannot tolerate more?
The 20-Degree Protocol: Design and Findings
Van Campen, Rowe, and colleagues recruited severe ME/CFS patients who were bedbound or near-bedbound and could not tolerate the standard 70-degree tilt protocol. They applied a modified head-up tilt to only 20 degrees — a mild orthostatic challenge that creates gravitational redistribution of blood but at a fraction of the magnitude produced by conventional testing. Cerebral blood flow velocity was measured throughout using transcranial Doppler ultrasonography. Heart rate and blood pressure were monitored continuously.
Even at 20 degrees, the severe ME/CFS patients reported significant orthostatic symptoms. The Doppler measurements confirmed the physiological correlate: measurable reductions in cerebral blood flow velocity compared to the supine baseline. The brain was receiving less blood at 20 degrees of tilt than when the patient was lying flat. The regulatory mechanisms that should compensate for even this minimal gravitational challenge were not providing adequate compensation.
Heart rate and blood pressure did not show changes meeting standard diagnostic criteria. The tachycardia threshold for POTS was not crossed. Blood pressure did not fall to meet orthostatic hypotension criteria. From the perspective of conventional vital sign monitoring, the test produced a normal result. From the perspective of cerebral blood flow measurement, it showed meaningful hypoperfusion at an angle that most patients can tolerate without difficulty. This is the same pattern van Campen and Rowe have documented across multiple studies: normal peripheral vital signs, abnormal brain blood flow. The tools determine what you can see.
The Threshold Problem: What 20 Degrees Reveals About Severity
The gravitational mechanics of orthostatic stress are scalar. Every degree of head-up tilt from horizontal adds a small increment of gravitational pressure for blood to pool downward away from the brain. At 70 degrees, the pooling challenge is substantial — this is why healthy people can tolerate it without symptoms while patients with POTS or OI develop tachycardia and other compensatory responses. At 20 degrees, the pooling challenge is modest — a typical healthy person would experience essentially no symptoms at 20 degrees of tilt, and their CBF would remain near supine values.
The finding that severe ME/CFS patients show significant CBF reduction at 20 degrees means their CBF regulatory reserve is so small that even the minimal gravitational challenge of 20-degree tilt exceeds what their cardiovascular and cerebrovascular systems can compensate for. This is a qualitatively different physiological state from moderate ME/CFS or from ambulatory POTS patients who decompensate at 70 degrees. The severe patients are not failing to compensate for a large challenge. They are failing to compensate for a very small one.
This has direct clinical implications for understanding what activities impose physiological stress on severe ME/CFS patients. A 20-degree head-up position is roughly the elevation you would achieve lying in a hospital bed with the head slightly raised, or sitting in a reclining chair. The 2023 study data establish that this level of positional change is sufficient to produce measurable cerebral hypoperfusion in bedbound patients. Activities that seem trivial from a medical standpoint — being slightly elevated in bed, sitting in a wheelchair for transport — may be repeatedly producing cerebral perfusion deficits in this population.
Why Standard Tilt Testing Produces Invalid Results in Severe ME/CFS
When a bedbound ME/CFS patient is evaluated with a standard 70-degree tilt protocol, the result is not a valid negative if no diagnostic thresholds are crossed. It is a test calibrated for the wrong patient. The stimulus was too large for the patient to tolerate completely, the thresholds were designed for a different population, and the measurement tools — heart rate and blood pressure — are not the measurements that reveal the condition's primary mechanism.
The van Campen and Rowe body of work has established this point across multiple studies and patient severity levels. The 2023 paper adds the specific finding that the relevant physiological threshold in severe ME/CFS may be as low as 20 degrees of tilt — a finding that reframes what counts as a physiological stimulus requiring evaluation in this population. If the goal is to detect cerebral blood flow impairment in bedbound ME/CFS patients, a 70-degree tilt protocol is excessive. A 20-degree protocol with transcranial Doppler measurement of CBF is what the physiology indicates is needed.
What This Means for Evaluation and Care
For patients who are severely affected by ME/CFS and have been evaluated with standard tilt protocols — or who have been told their evaluation was normal because heart rate and blood pressure did not cross diagnostic thresholds — the 2023 van Campen data establish several things specifically. The standard test was not designed for your severity level. The stimulus it applies was larger than your threshold for physiological decompensation. The measurements it uses do not capture cerebral blood flow. A normal result on those terms is not evidence that your physiology is normal. It is evidence that the test was not measuring what is wrong.
For clinicians evaluating bedbound ME/CFS patients, the practical message is that standard tilt protocols require modification for this population. The 20-degree angle documented in this study as sufficient to produce CBF reduction provides a lower threshold for modified protocol design. Measurement should include transcranial Doppler CBF velocity rather than relying solely on peripheral vital signs. The combination of lower tilt angle and direct CBF measurement is the approach the physiology of severe ME/CFS indicates — and it is an approach the research already supports, even if clinical practice has not yet implemented it.